The evaluation of ovarian reserve after uterine artery embolizatio
Not Applicable
- Conditions
- uerine fibroma and bleeding.????????? ??????? ???
- Registration Number
- IRCT201202163461N5
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 66
Inclusion Criteria
age 25-45, sever vaginal bleeding , 16 week mass, anemia and pressure effect caused by uterine fibroma.
exclusion criteria: pelvic malignancy, ovarian patology,pelvic infection,substance media sensitivity.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method FSH level. Timepoint: Third day of month before and third day six month after both procedures. Method of measurement: serum level , mIU/ cc.
- Secondary Outcome Measures
Name Time Method umber of dominant follicle between 12-14 days of cycle. Timepoint: Before and 6 month after intervention. Method of measurement: One dominant follicle by sonography.;Hb level. Timepoint: Before and 6 month after intervention. Method of measurement: Blood level.;Duration of hospitalization. Timepoint: hospitalization time. Method of measurement: The number of days hospitalization through intervention.;Time required to return normal activity. Timepoint: The number of weeks to return normal activity. Method of measurement: weeks.;Pain level after intervention. Timepoint: one week after intervention. Method of measurement: 1-10 score.;Cost of procedure. Timepoint: cost of hospitalization and. Method of measurement: Rials.;Repeat intervention. Timepoint: By 6 month after first intervention. Method of measurement: Operation and hormonal drugs.;Patients symptoms. Timepoint: 6 month after intervention. Method of measurement: Hot flash, bleeding,pain,.